Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2010/Almirall-and-Ironwood-Announce-Positive-Results-from-a-Phase-3-Trial-with-Linaclotide-in-Patients-with-Irritable-Bowel-Syndrome-with-Constipation/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here